These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22226681)

  • 1. Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers - I: formulation, lyoavailability and in vitro antimalarial activity assessment.
    Yaméogo JB; Gèze A; Choisnard L; Putaux JL; Gansané A; Sirima SB; Semdé R; Wouessidjewe D
    Eur J Pharm Biopharm; 2012 Apr; 80(3):508-17. PubMed ID: 22226681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles.
    Yaméogo JB; Gèze A; Choisnard L; Putaux JL; Mazet R; Passirani C; Keramidas M; Coll JL; Lautram N; Bejaud J; Semdé R; Wouessidjewe D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):683-94. PubMed ID: 25204521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of intravenously administered artemisinin-loaded surface-decorated amphiphilic γ-cyclodextrin nanoparticles.
    Gérard Yaméogo JB; Mazet R; Wouessidjewe D; Choisnard L; Godin-Ribuot D; Putaux JL; Semdé R; Gèze A
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110281. PubMed ID: 31753335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
    Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activity of 10-alkyl/aryl esters and -aminoethylethers of artemisinin.
    Cloete TT; Krebs HJ; Clark JA; Connelly MC; Orcutt A; Sigal MS; Guy RK; N'Da DD
    Bioorg Chem; 2013 Feb; 46():10-6. PubMed ID: 23247255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
    Emami J; Yousefian H; Sadeghi H
    J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel artemisinin-quinine hybrid with potent antimalarial activity.
    Walsh JJ; Coughlan D; Heneghan N; Gaynor C; Bell A
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3599-602. PubMed ID: 17482816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin.
    Steyn M; N'Da DD; Breytenbach JC; Smith PJ; Meredith S; Breytenbach WJ
    J Pharm Pharmacol; 2011 Feb; 63(2):278-86. PubMed ID: 21235593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension.
    Kakran M; Sahoo NG; Li L; Judeh Z
    J Pharm Pharmacol; 2010 Apr; 62(4):413-21. PubMed ID: 20604829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
    Sharma N; Mohanakrishnan D; Sharma UK; Kumar R; Richa ; Sinha AK; Sahal D
    Eur J Med Chem; 2014 May; 79():350-68. PubMed ID: 24747290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of antimalarial agent artemisinin with cyclodextrins.
    Usuda M; Endo T; Nagase H; Tomono K; Ueda H
    Drug Dev Ind Pharm; 2000 Jun; 26(6):613-9. PubMed ID: 10826109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
    Chadha R; Gupta S; Pathak N
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
    Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
    Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
    Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
    Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline.
    Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin.
    Cloete TT; Wilma Breytenbach J; Kock Cd; Smith PJ; Breytenbach JC; N'da DD
    Bioorg Med Chem; 2012 Aug; 20(15):4701-9. PubMed ID: 22750008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.
    Shah SM; Ullah F; Khan S; Shah SM; de Matas M; Hussain Z; Minhas MU; AbdEl-Salam NM; Assi KH; Isreb M
    Drug Des Devel Ther; 2016; 10():3837-3850. PubMed ID: 27920499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles: formulation, antimalarial and toxicity assessments.
    Dauda K; Busari Z; Morenikeji O; Afolayan F; Oyeyemi O; Meena J; Sahu D; Panda A
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):977-985. PubMed ID: 29119735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.